Skip to content
2000
Volume 6, Issue 4
  • ISSN: 2666-7967
  • E-ISSN: 2666-7975

Abstract

Long COVID is a syndrome with common symptoms such as dyspnea, fatigue, cognitive dysfunction, chest pain, and other conditions that have a major impact on affected patients. These are some of the risk factors of fluctuating or relapsing states that occur in patients with a history of SARS-CoV-2 infection of at least 2 months. This study addressed the challenges faced by healthcare professionals in defining and managing this condition, which manifests with diverse and inconsistent symptoms that last more than three months after infection. A systematic review of the literature over the period 2020-2023 has been conducted to focus on the evolution of the long COVID phenomenon worldwide. The study aimed to describe the spectrum of symptoms associated with Long COVID by comparing management approaches in European and Latin American countries. Disparities in research, guidelines, and treatment strategies between these regions have been identified, posing challenges for accurate diagnosis and effective treatment in Latin America. It is crucial to propose further studies and research on the mechanistic understanding of the symptoms of long COVID and the development of targeted treatments. Eventually, it is critical to address the wide disparities in long COVID research and treatment between Europe and Latin America to ensure equitable access to information and health care for people affected, considering both physical and mental health aspects.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/covid/10.2174/0126667975311456240708070459
2024-07-15
2025-10-03

  • From This Site

    /content/journals/covid/10.2174/0126667975311456240708070459
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. SabbatucciM. VitielloA. ClementeS. Omicron variant evolution on vaccines and monoclonal antibodies.Inflammopharmacology20233141779178810.1007/s10787‑023‑01253‑6 37204696
     [Google Scholar]
  2. YongS.J. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments.Infect Dis2021531073775410.1080/23744235.2021.1924397 34024217
     [Google Scholar]
  3. CarfìA. BernabeiR. LandiF. Persistent symptoms in patients after acute COVID-19.JAMA2020324660360510.1001/jama.2020.12603 32644129
     [Google Scholar]
  4. BarmanM.P. RahmanT. BoraK. BorgohainC. COVID-19 pandemic and its recovery time of patients in India: A pilot study.Diabetes Metab. Syndr.20201451205121110.1016/j.dsx.2020.07.004 32673841
     [Google Scholar]
  5. NatarajanA. ShettyA. DelanerolleG. A systematic review and meta-analysis of long COVID symptoms.Syst. Rev.20231218810.1186/s13643‑023‑02250‑0 37245047
     [Google Scholar]
  6. DavisH.E. McCorkellL. VogelJ.M. TopolE.J. Long COVID: major findings, mechanisms and recommendations.Nat. Rev. Microbiol.202321313314610.1038/s41579‑022‑00846‑2 36639608
     [Google Scholar]
  7. GiulianoM. TipleD. AgostoniP. Italian good practice recommendations on management of persons with Long-COVID.Front. Public Health202311112214110.3389/fpubh.2023.1122141 37151592
     [Google Scholar]
  8. FerraraF. ZavaletaE. VitielloA. The direct correlation between COVID-19 and attention deficit/hyperactivity disorder (ADHD).Eur. Neuropsychopharmacol.202373626410.1016/j.euroneuro.2023.04.010 37121166
     [Google Scholar]
  9. PerumalR. ShunmugamL. NaidooK. Long COVID: A review and proposed visualization of the complexity of long COVID.Front. Immunol.202314111746410.3389/fimmu.2023.1117464 37153597
     [Google Scholar]
  10. LancetT. Long COVID: 3 years in.Lancet20234011037979510.1016/S0140‑6736(23)00493‑2 36906338
     [Google Scholar]
  11. ZaimS. ChongJ.H. SankaranarayananV. HarkyA. COVID-19 and multiorgan response.Curr. Probl. Cardiol.202045810061810.1016/j.cpcardiol.2020.100618 32439197
     [Google Scholar]
  12. AppleA.C. OddiA. PelusoM.J. Risk factors and abnormal cerebrospinal fluid associate with cognitive symptoms after mild COVID‐19.Ann. Clin. Transl. Neurol.20229222122610.1002/acn3.51498 35043593
     [Google Scholar]
  13. CheungK.S. HungI.F.N. ChanP.P.Y. Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from a Hong Kong cohort: systematic review and meta-analysis.Gastroenterology20201591819510.1053/j.gastro.2020.03.065 32251668
     [Google Scholar]
  14. RokkasT. Gastroenterology and digestive endoscopy, general hospital of perugia (Raffaele Manta), Italy.Ann. Gastroenterol.2020334355365 32624655
     [Google Scholar]
  15. CaiY. YeL.P. SongY.Q. Liver injury in COVID-19: Detection, pathogenesis, and treatment.World J. Gastroenterol.202127223022303610.3748/wjg.v27.i22.3022 34168405
     [Google Scholar]
  16. El MohebM. NaarL. ChristensenM.A. Gastrointestinal complications in critically ill patients with and without COVID-19.JAMA2020324181899190110.1001/jama.2020.19400 32970139
     [Google Scholar]
  17. RudroffT. FietsamA.C. DetersJ.R. BryantA.D. KamholzJ. Post-COVID-19 fatigue: potential contributing factors.Brain Sci.20201012101210.3390/brainsci10121012 33352638
     [Google Scholar]
  18. GrahamE.L. ClarkJ.R. OrbanZ.S. Persistent neurologic symptoms and cognitive dysfunction in non‐hospitalized COVID‐19 “long haulers”.Ann. Clin. Transl. Neurol.2021851073108510.1002/acn3.51350 33755344
     [Google Scholar]
  19. WierdsmaN.J. KruizengaH.M. KoningsL.A.M.L. Poor nutritional status, risk of sarcopenia and nutrition related complaints are prevalent in COVID-19 patients during and after hospital admission.Clin. Nutr. ESPEN20214336937610.1016/j.clnesp.2021.03.021 34024542
     [Google Scholar]
  20. LansingR.W. GracelyR.H. BanzettR.B. The multiple dimensions of dyspnea: Review and hypotheses.Respir. Physiol. Neurobiol.20091671536010.1016/j.resp.2008.07.012 18706531
     [Google Scholar]
  21. ViscontiN.R.G.R. Cailleaux-CezarM. CaponeD. Long-term respiratory outcomes after COVID-19: a Brazilian cohort study.Rev. Panam. Salud Publica202246110.26633/RPSP.2022.187 36406289
     [Google Scholar]
  22. HentschL. CocettaS. AllaliG. Dificultad respiratoria y COVID-19: Un llamado a la investigación.Kompass Neumología202241212810.1159/000521663
     [Google Scholar]
  23. MagroC. MulveyJ.J. BerlinD. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases.Transl. Res.202022011310.1016/j.trsl.2020.04.007 32299776
     [Google Scholar]
  24. MatschkeJ. LütgehetmannM. HagelC. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series.Lancet Neurol.2020191191992910.1016/S1474‑4422(20)30308‑2 33031735
     [Google Scholar]
  25. TanaC. BentivegnaE. ChoS.J. Long COVID headache.J. Headache Pain20222319310.1186/s10194‑022‑01450‑8 35915417
     [Google Scholar]
  26. KrymchantowskiA.V. Silva-NétoR.P. JevouxC. KrymchantowskiA.G. Indomethacin for refractory COVID or post-COVID headache: A retrospective study.Acta Neurol. Belg.2022122246546910.1007/s13760‑021‑01790‑3 34546559
     [Google Scholar]
  27. ChhabraN. GrillM.F. SinghR.B.H. Post-COVID headache: A literature review.Curr. Pain Headache Rep.2022261183584210.1007/s11916‑022‑01086‑y 36197571
     [Google Scholar]
  28. FialaK. MartensJ. Abd-ElsayedA. Post-COVID pain syndromes.Curr. Pain Headache Rep.202226537938310.1007/s11916‑022‑01038‑6 35267156
     [Google Scholar]
  29. NiW. YangX. YangD. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19.Crit. Care202024142210.1186/s13054‑020‑03120‑0 32660650
     [Google Scholar]
  30. LorenzoC. FrancescaB. FrancescoP. ElenaC. LucaS. PaoloS. Acute pulmonary embolism in COVID-19 related hypercoagulability.J. Thromb. Thromboly.2020501223226
     [Google Scholar]
  31. VallejoN. TeisA. MateuL. Bayés-GenísA. Persistent chest pain after recovery of COVID-19: microvascular disease-related angina?Europ Heart J.202153ytab105
     [Google Scholar]
  32. CiofaniJ.L. HanD. AllahwalaU.K. AsrressK.N. BhindiR. Internet search volume for chest pain during the COVID-19 pandemic.Am. Heart J.2021231157159
     [Google Scholar]
  33. Silva AndradeB. SiqueiraS. de Assis SoaresW.R. Long-COVID and post-COVID health complications: an up-to-date review on clinical conditions and their possible molecular mechanisms.Viruses202113470010.3390/v13040700 33919537
     [Google Scholar]
  34. CodasM.E. Torres VillagraK.A. Barrios GayosoC.A. CodasM.E. Torres VillagraK.A. Barrios GayosoC.A. Long COVID, more frequent symptoms in post-COVID-19 patients, Paraguay, 2021.Virt J Parag Soc Int Med2022927583
     [Google Scholar]
  35. FeterN. CaputoE.L. LeiteJ.S. Prevalence and factors associated with long COVID in adults from Southern Brazil: findings from the PAMPA cohort.Cad. Saude Publica20233912e0009802310.1590/0102‑311xen098023
     [Google Scholar]
  36. WeichS. Mental health after COVID-19.BMJ2022376O32610.1136/bmj.o326
     [Google Scholar]
  37. BachmeierB.E. HölzleS. GasserM. van den AkkerM. How do german general practitioners manage long-/post-COVID? A qualitative study in primary care.Viruses2023154101610.3390/v15041016 37112996
     [Google Scholar]
  38. AntoniouK.M. VasarmidiE. RussellA.M. AndrejakC. CrestaniB. DelcroixM. European respiratory society statement on long COVID follow-up.Eur. Respir. J.2022602210217410.1183/13993003.02174‑2021
     [Google Scholar]
  39. Gárces GranobleI.G. Loor IntriagoM.F. Alcocer DíazS. Secuelas post-COVID-19 en adultos de Latinoamérica.MQRInvestigar2023712778279810.56048/MQR20225.7.1.2023.2778‑2798
     [Google Scholar]
  40. PiedraJ de las MS. HernándezE.I.R. CuellarC.T. MachadoV.D.T. Instruments for assessing sequelae in post-COVID-19 patients. Its usefulness in rehabilitation.Rev Cub of Med Fis and Rehab2020123Available from: https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=101586 [cited May 27, 2024].
     [Google Scholar]
  41. Bresser PereiraLC Brazil: effects of COVID-19 and recovery.2020Available from: https://repositorio.cepal.org/server/api/core/bitstreams/355b81f4-00b5-430f-b915-14d86fac302b/content
    [Google Scholar]
  42. Characterization and permanence of signs and symptoms in positive and negative COVID-19 patients who attend the Pulmonology Clinic of the General Hospital of Luque, Paraguay.Available from: http://scielo.iics.una.py/scielo.php?pid=S2307-33492021000100041&script=sci_arttext [cited May 27, 2024].
  43. Carod-ArtalF.J. Post-COVID-19 syndrome: epidemiology, diagnostic criteria and pathogenic mechanisms involved.Rev. Neurol.20217211384396 34042167
     [Google Scholar]
  44. Torres-CuevasJ.L. Gil-GuzmánO.A. Torres-EscalanteJ.L. Potential health consequences from COVID-19 in Mexico: What should we expect??Archivos en Medicina Familiar20222416773
     [Google Scholar]
  45. PitossiF. The possible role of inflammation in the neurological sequelae of COVID-19.Neurología Argentina202113313513610.1016/j.neuarg.2021.09.001
     [Google Scholar]
  46. Caballero-AlvaradoJ. Camacho-VargasE. Rojas-SánchezP. Long-term effect of SARS-CoV-2 infection: Post-COVID-19 neurological syndrome.Magazine of the Medical Corps Almanzor Aguinaga Asenjo National Hospital202114340440910.35434/rcmhnaaa.2021.143.1284
     [Google Scholar]
  47. AnzulezD.A.Z. VélezL.C.F. MacíasC.E.B. Long-term COVID-19, muscular, neurological and respiratory consequences.Latin Science Multidisciplinary Scientific Magazine2022614298431110.37811/cl_rcm.v6i1.1800
     [Google Scholar]
  48. Angarita-FonsecaA. Torres-CastroR. Benavides-CordobaV. Exploring long COVID condition in Latin America: Its impact on patients’ activities and associated healthcare use.Front. Med.202310116862810.3389/fmed.2023.1168628 37153089
     [Google Scholar]
  49. COVID-19 rapid guideline: managing the long-term effects of COVID-19.Available from: https://paho-covid-prod.atmire.com/handle/20.500.12663/2515 [cited May 27, 2024].
  50. Alvarez-MorenoC.A. PinedaJ. BareñoA. EspitiaR. RengifoP. Long COVID-19 in Latin America: Low prevalence, high resilience or low surveillance and difficulties accessing health care?Travel Med. Infect. Dis.20235110249210.1016/j.tmaid.2022.102492 36368518
     [Google Scholar]
  51. SakhamuriS.M. JankieS. PereiraL.M.P. Calling on Latin America and the Caribbean countries to recognise the disability from long COVID.Lancet Reg. Health Am.202215100362
     [Google Scholar]
  52. BenítezM.A. VelascoC. SequeiraA.R. HenríquezJ. MenezesF.M. PaolucciF. Responses to COVID-19 in five Latin American countries.Health Policy Technol.20209452555910.1016/j.hlpt.2020.08.014 32874863
     [Google Scholar]
  53. GallegosM. PortilloN. Post-COVID-19 in Latin America: a call for research and public policies.Cir. Cir.2023912294295 37084308
     [Google Scholar]
  54. GallegosM. MartinoP. RazumovskiyA. PortilloN. CalandraM. Caycho-RodríguezT. Post COVID-19 Syndrome in Latin America and the Caribbean: a call for attention.Rev. Med. Rosario2022883114118
     [Google Scholar]
  55. Del CarpioX.V. OlivieriS.D. Rivadeneira AlavaA.M. Winkler-SealesH.J. CamachoA. HernándezP. Long COVID: The Persistent Effects of the Pandemic on the Labor Markets of Latin America and the CaribbeanSpanish.2022Available from: https://www.undp.org/latin-america/publications/long-covid-extended-effects-pandemic-labor-markets-latin-america-and-caribbean
    [Google Scholar]
  56. TajerC. María JoséM. JavierM. Post COVID-19 syndrome. Severity and evolution in 4673 health care workers.Medicina2023835669682
     [Google Scholar]
  57. Wong ChewR.M. Ángel AmbrocioA.H. Bautista CarbajalP. Effectiveness of COVID-19: Revisiting the literatura.Acta Med. Grupo Ángeles202119342142810.35366/101741
     [Google Scholar]
  58. JacobsJ.J.L. Persistent SARS-2 infections contribute to long COVID-19.Med. Hypotheses202114911053810.1016/j.mehy.2021.110538 33621843
     [Google Scholar]
  59. Cherrez-OjedaI. Cortés-TellesA. Gochicoa-RangelL. Challenges in the Management of Post-COVID-19 Pulmonary Fibrosis for the Latin American Population.J. Pers. Med.2022129139310.3390/jpm12091393 36143178
     [Google Scholar]
  60. ChoiE.M. COVID-19 vaccines for low- and middle-income countries.Trans. R. Soc. Trop. Med. Hyg.2021115544745610.1093/trstmh/trab045 33733663
     [Google Scholar]
  61. Al-AlyZ. Prevention of long COVID: progress and challenges.Lancet Infect. Dis.202323777677710.1016/S1473‑3099(23)00287‑6 37156258
     [Google Scholar]
/content/journals/covid/10.2174/0126667975311456240708070459
Loading
Spectrum of Long COVID Symptoms and Management Approaches in Europe and Latin America
Coronaviruses 6, E150724231969 (2025); https://doi.org/10.2174/0126667975311456240708070459
/content/journals/covid/10.2174/0126667975311456240708070459
/content/journals/covid/10.2174/0126667975311456240708070459
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): chest pain; dyspnea; fatigue; healthcare management; long COVID; SARS-CoV-2

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test